Skip to main content
Caplight Logo









Manual

Manual

Private
LondonHealthcare & Life Scienceshttps://www.manual.co/

Last Round

Debt

Nov 12, 2025

Est. Valuation

$69.8M

Total Funding Raised

$352.5M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Manual is a health and wellness company that provides a digital platform offering medical support, diagnostics, and treatments for men's health conditions including weight management, hair loss, and sexual health.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, D2C Brands, Subscription Commerce, E-commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

telehealthtelemedicinedirect-to-consumerDTConline pharmacydigital healthprescription deliveryweight managementGLP-1subscription pharmacysexual healthhair loss treatmentat-home diagnosticshealth teche-health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Manual Comparables

Compare Manual with similar companies based on industry and business-model similarity.

Manual comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Numan
93%
Hims & Hers Health, Inc.
86%
Mosh
82%

Manual Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtNov 12, 2025
DebtNov 1, 2024
Series BSep 15, 2024
Series BMay 1, 2024
Series AMar 30, 2021
Seed
Jan 15, 2019

Key People

Founding team and executive leadership

Faruk Ah

Deputy CTO

Executive Team

Manual Investors

Notable investors and investment history

Manual investors
InvestorRounds
GISEVSeries A
CASSIUSSeed
WaldencastSeries A
Felix CapitalSeries B, Series A, Seed
General CatalystDebt
FJ LabsSeries A
Sonoma Brands CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 30, 2026

    Published outcomes study conducted with Harvard Medical School.

  • Apr 30, 2026

    Collaborating with University of Oxford, Imperial College London, and University of Bristol.

Manual Filings

Explore SEC and related filing metadata, where available.

Manual filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Manual's valuation, stock price, and market status.

Is Manual a public or private company?

Manual is a private company.

What is the current stock price of Manual?

Manual is a private company with no public stock price. No recent secondary market data is available.

How much is Manual worth (valuation)?

Manual's valuation is estimated at $69.8M based on funding round data.

Can I buy Manual stock?

Manual shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Manual's last funding round?

Manual's most recent funding round was Debt on March 30, 2021.

Who are the main investors in Manual?

Key investors in Manual include Felix Capital, General Catalyst, Octopus Ventures, Cherry Ventures.

Will Manual IPO soon?

No public IPO plans have been announced for Manual.

How can I track Manual secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Manual's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range267
Year Founded2018
Last FundingNov 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?